Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 4, 2011, Pages 720-730

  Ruwanpura, Saleela M ^a   McLeod, Louise ^a   Miller, Alistair ^a   Jones, Jessica ^b   Bozinovski, Steven ^b   Vlahos, Ross ^b   Ernst, Matthias ^c   Armes, Jane ^d   Bardin, Philip G ^e   Anderson, Gary P ^b   Jenkins, Brendan J ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d MATER HOSPITAL   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

Author keywords

Apoptosis; Cytokines; gp130; IL 6; Receptor

Indexed keywords

CIGARETTE SMOKE; GLYCOPROTEIN GP 130; HOMODIMER; INTERLEUKIN 11; INTERLEUKIN 6; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE CONTROL; GENE MUTATION; GENE TARGETING; GENETIC COMPLEMENTATION; INTRACELLULAR SIGNALING; LUNG ALVEOLUS CELL; LUNG EMPHYSEMA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PNEUMONIA; PROTEIN EXPRESSION; UPREGULATION;

AGING; ANIMALS; APOPTOSIS; CYTOKINE RECEPTOR GP130; INTERLEUKIN-6; MICE; MICE, KNOCKOUT; PULMONARY ALVEOLI; PULMONARY EMPHYSEMA; SIGNAL TRANSDUCTION; SMOKE; SMOKING; TIME FACTORS; UP-REGULATION;

MUS;

EID: 80053647514     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0462OC     Document Type: Article

References (50)

1. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003;22: 672-688. (Pubitemid 37258549)
2. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006;7:53.
3. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2: 50-60. (Pubitemid 40562963)
4. Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, Inglese M, McLoughlin RM, Jones SA, Topley N, et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med 2005;11:845-852. (Pubitemid 41161116)
5. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, et al. Blockade of interleukin 6 Trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 2000;6:583-588. (Pubitemid 30305911)
6. Yanbaeva DG, Dentener MA, Spruit MA, Houwing-Duistermaat JJ, Kotz D, Passos VL, Wouters EF. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. BMC Med Genet 2009;10:23.
7. He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, et al. Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 2009;64:698-704.
8. Klein W, Rohde G, Arinir U, Hagedorn M, Durig N, Schultze- Werninghaus G, Epplen JT. A promoter polymorphism in the interleukin 11 gene is associated with chronic obstructive pulmonary disease. Electrophoresis 2004;25:804-808. (Pubitemid 38401368)
9. Song W, Zhao J, Li Z. Interleukin-6 in bronchoalveolar lavage fluid from patients with COPD. Chin Med J (Engl) 2001;114:1140-1142.
10. Bozinovski S, Hutchinson A, Thompson M, Macgregor L, Black J, Giannakis E, Karlsson AS, Silvestrini R, Smallwood D, Vlahos R, et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:269-278. (Pubitemid 351198369)
11. Gerhartz C, Heesel B, Sasse J, Hemmann U, Landgraf C, Schneider- Mergener J, Horn F, Heinrich PC, Graeve L. Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130: I. Definition of a novel phosphotyrosine motif mediating Stat1 activation. J Biol Chem 1996;271:12991-12998.
12. Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ, Malki S, Alderman BM, Grail D, Hollande F, et al. Reciprocal regulation of gastrointestinal homeostasis by Shp2 and Stat-mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002;8:1089-1097. (Pubitemid 35175963)
13. Kuhn C III, Homer RJ, Zhu Z, Ward N, Flavell RA, Geba GP, Elias JA. Airway hyperresponsiveness and airway obstruction in transgenic mice: morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Cell Mol Biol 2000;22: 289-295. (Pubitemid 30343355)
14. Betz UA, Bloch W, van den Broek M, Yoshida K, Taga T, Kishimoto T, Addicks K, Rajewsky K, Muller W. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med 1998; 188:1955-1965. (Pubitemid 28536782)
15. Jenkins BJ, Ruwanpura S, Miller A, McLeod L, Jones J, Bardin PG, Anderson G. Genetic elucidation of the pathological role of interleukin-6 in emphysema. Am J Respir Crit Care Med 2010;181:A5056.
16. Jenkins BJ, Jones J, McLeod L, Miller A, Bardin P, Anderson G, Ruwanpura S. Deregulated activation of cytokine signaling pathways in emphysema. Am J Respir Crit Care Med 2009;179:A2221.
17. Jenkins BJ, Roberts AW, Greenhill CJ, Najdovska M, Lundgren-May T, Robb L, Grail D, Ernst M. Pathologic consequences of Stat3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Blood 2007;109:2380-2388. (Pubitemid 46425878)
18. Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS, Hughes NR, et al. Stat3 and Stat1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008;118: 1727-1738. (Pubitemid 351632376)
19. Vlahos R, Bozinovski S, Jones J, Powell J, Gras J, Lilja A, Hansen MJ, Gualano RC, Irving L, Anderson GP. Differential protease, innate immunity, and Nf-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 2006;290:L931-L945. (Pubitemid 43725055)
20. Ochs M. A brief update on lung stereology. J Microsc 2006;222:188-200. (Pubitemid 44035814)
21. Collins RA, Gualano RC, Zosky GR, Atkins CL, Turner DJ, Colasurdo GN, Sly PD. Hyperresponsiveness to inhaled but not intravenous methacholine during acute respiratory syncytial virus infection in mice. Respir Res 2005;6:142.
22. Amy RW, Bowes D, Burri PH, Haines J, Thurlbeck WM. Postnatal growth of the mouse lung. J Anat 1977;124:131-151. (Pubitemid 8187543)
23. Hantos Z, Adamicza A, Janosi TZ, Szabari MV, Tolnai J, Suki B. Lung volumes and respiratory mechanics in elastase-induced emphysema in mice. J Appl Physiol 2008;105:1864-1872.
24. Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc 2008;5:475-477. (Pubitemid 351669173)
25. Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, Tanou K, Nikoulis DJ, Georgoulias P, Zakynthinos E, Gourgoulianis KI, et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med 2010;104:275-282.
26. Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 2003;28:555-562. (Pubitemid 36543402)
27. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002;26:602-609. (Pubitemid 34315869)
28. Corbel M, Belleguic C, Boichot E, Lagente V. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol 2002;18:51-61. (Pubitemid 34269789)
29. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573. (Pubitemid 43139720)
30. Martin E, Truscott EA, Bailey TC, Leco KJ, McCaig LA, Lewis JF, Veldhuizen RA. Lung mechanics in the Timp3 null mouse and its response to mechanical ventilation. Exp Lung Res 2007;33:99-113. (Pubitemid 46558345)
31. Tsuji T. Aoshiba k, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006;174:886-893. (Pubitemid 44564788)
32. Cork BA, Tuckerman EM, Li TC, Laird SM. Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro. Mol Hum Reprod 2002;8:841-848. (Pubitemid 35012472)
33. Chen Q, Rabach L, Noble P, Zheng T, Lee CG, Homer RJ, Elias JA. IL-11 receptor alpha in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2005;174:2305-2313. (Pubitemid 40223979)
34. Suzuki M, Betsuyaku T, Nagai K, Fuke S, Nasuhara Y, Kaga K, Kondo S, Hamamura I, Hata J, Takahashi H, et al. Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and COPD patients. Inhal Toxicol 2008;20:349-359. (Pubitemid 351323659)
35. Persengiev SP, Green MR. The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 2003;8:225-228. (Pubitemid 36749607)
36. Borrelli S, Candi E, Alotto D, Castagnoli C, Melino G, Vigano MA, Mantovani R. P63 regulates the caspase-8-flip apoptotic pathway in epidermis. Cell Death Differ 2009;16:253-263.
37. Cotteret S, Jaffer ZM, Beeser A, Chernoff J. P21-activated kinase 5 (PAK5) localizes to mitochondria and inhibits apoptosis by phosphorylating bad. Mol Cell Biol 2003;23:5526-5539. (Pubitemid 36951321)
38. Maier JK, Lahoua Z, Gendron NH, Fetni R, Johnston A, Davoodi J, Rasper D, Roy S, Slack RS, Nicholson DW, et al. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci 2002;22:2035-2043. (Pubitemid 35386504)
39. Gade P, Singh AK, Roy SK, Reddy SP, Kalvakolanu DV. Downregulation of the transcriptional mediator subunit MED1 contributes to the loss of expression of metastasis-associated DAPK1 in human cancers and cancer cells. Int J Cancer 2009;125:1566-1574.
40. Thatcher TH, McHugh NA, Egan RW, Chapman RW, Hey JA, Turner CK, Redonnet MR, Seweryniak KE, Sime PJ, Phipps RP. Role of CXCR2 in cigarette smoke-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol 2005;289:322-328.
41. Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal Phase III trial. Lancet 2008;371:998-1006. (Pubitemid 351389534)
42. Smolen J, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, Woodworth T, Alten R. OPTION Investigators: effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION Study): a double-blind, placebocontrolled, randomised trial. Lancet 2008;371:987-997. (Pubitemid 351392039)
43. Kida H, Mucenski ML, Thitoff AR, Le Cras TD, Park KS, Ikegami M, Muller W, Whitsett JA. Gp130-Stat3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol 2008;172:1542-1554. (Pubitemid 351793348)
44. Lian X, Qin Y, Hossain SA, Yang L, White A, Xu H, Shipley JM, Li T, Senior RM, Du H, et al. Overexpression of Stat3C in pulmonary epithelium protects against hyperoxic lung injury. J Immunol 2005; 174:7250-7256. (Pubitemid 40705694)
45. Tang K, Rossiter HB, Wagner PD, Breen EC. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 2004;97:1559-1566. (Pubitemid 39299378)
46. Fernandez P, Carretero J, Medina PP, Jimenez AI, Rodriguez-Perales S, Paz MF, Cigudosa JC, Esteller M, Lombardia L, Morente M, et al. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations. Oncogene 2004;23:5084-5091. (Pubitemid 38938742)
47. Koster MI, Lu SL, White LD, Wang XJ, Roop DR. Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression. Cancer Res 2006;66:3981-3986.
48. Chen ZH, Kim HP, Sciurba FC, Lee SJ, Feghali-Bostwick C, Stolz DB, Dhir R, Landreneau RJ, Schuchert MJ, Yousem SA, et al. EGR-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 2008;3:e3316.
49. Doz E, Noulin N, Boichot E, Guénon I, Fick L, Le Bert M, Lagente V, Ryffel B, Schnyder B, Quesniaux VF, et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MYD88 and IL-1R1/MYD88 signaling dependent. J Immunol 2008;180:1169-1178.
50. Halappanavar S, Russell M, Stampfli MR, Williams A, Yauk CL. Induction of the interleukin 6/signal transducer and activator of transcription pathway in the lungs of mice sub-chronically exposed to mainstream tobacco smoke. BMC Med Genomics 2009;21:56.